Quarterly report [Sections 13 or 15(d)]

Earnings Per Share

v3.25.3
Earnings Per Share
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS PER SHARE.

10. EARNINGS PER SHARE.

 

The following tables compute basic and diluted earnings per share (in thousands, except per share data):

 

    Three Months Ended September 30, 2025  
    Income
Numerator
    Shares
Denominator
    Per-Share
Amount
 
Net income   $ 14,208                  
Less: Preferred stock dividends     (319 )                
Basic and diluted income per share:                        
Income attributable to common stockholders   $ 13,889       74,777     $ 0.19  

 

    Nine Months Ended September 30, 2025  
    Loss
Numerator
    Shares
Denominator
    Per-Share
Amount
 
Net loss   $ (8,468 )                
Less: Preferred stock dividends     (946 )                
Basic and diluted loss per share:                        
Loss attributable to common stockholders   $ (9,414 )     74,415     $ (0.13 )

 

    Three Months Ended September 30, 2024  
    Loss
  Numerator
    Shares
Denominator
    Per-Share
Amount
 
Net loss   $ (2,441 )                
Less: Preferred stock dividends     (319 )                
Basic and diluted loss per share:                        
Loss attributable to common stockholders   $ (2,760 )     73,835     $ (0.04 )

  

    Nine Months Ended September 30, 2024  
    Loss
Numerator
    Shares
Denominator
    Per-Share
Amount
 
Net loss   $ (17,272 )                
Less: Preferred stock dividends     (950 )                
Basic and diluted loss per share:                        
Loss attributable to common stockholders   $ (18,222 )     73,364     $ (0.25 )

  

There were an additional aggregate potentially dilutive weighted-average shares of 981,000 from convertible securities outstanding for the three and nine months ended September 30, 2025 and September 30, 2024. These securities were not considered in calculating diluted net income (loss) per share for the three and nine months ended September 30, 2025 and 2024, as their effects would have been anti-dilutive.